BERLIN--(BUSINESS WIRE)--MagForce Nanotechnologies AG (FWB:MF6) has announced the appointment of Dr. Peter Heinrich, until now the deputy chairman of its supervisory board, as the company’s new ...

Cancer therapeutic business MagForce Nanotechnologies AG (FSX:MF6), a subsidiary of venture capital firm Nanostart, said Monday that it has expanded its management team with five new appointments.

FRANKFURT, Germany & BERLIN--(BUSINESS WIRE)--Nanostart (OTCQX: NASRY) subsidiary MagForce Nanotechnologies AG (FSE: MF6), a leading medical technology company focusing on nanomedicine in oncology ...

MagForce Nanotechnologies AG, has announced that the Charité-Universitätsmedizin Berlin published the establishment of its NanoTherm therapy center for the treatment of recurrent brain tumors. The ...

BERLIN--(BUSINESS WIRE)--June 28, 2010-- Following two decades of intensive research and development efforts, MagForce Nanotechnologies AG, a Berlin-based medical technology company founded in ...

Indeed, MagForce Nanotechnologies AG, based in Berlin, is exploring the idea of making its tiny magnetic beads do double duty: heat-treat tumors in the body and at the same time deliver drugs ...

Nanostart (ETR:NNS) portfolio company, MagForce Nanotechnologies (FSE:MF6), a company that develops cancer treatment, announced Thursday that it is now prepared to launch its products commercially.

Meanwhile, a very visible innovation has come from German start-up Magforce Nanotechnologies which has used nanotech principles in equipment to eliminate cancerous tumors in some patients ...

MagForce Nanotechnologies AG / MagForce Nanotechnologies AG Announces Establishment of NanoTherm® Therapy Treatment Center at Charité University Medical Center . Processed and transmitted by ...